MMP9 and Alzheimer disease: Furthermore, MMP-9 is expressed in senile plaques, NFTs, and the vascular walls of human AD brains as well as in Aβ-stimulated astrocytes and activated microglia, and its inhibition is therapeutically beneficial in a transgenic mouse model of AD (124–127).